SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION;SEOUL NATIONAL UNIVERSITY HOSPITAL;TOOLGEN INCORPORATED
发明人:
Jeong Hun KIM,Sung Wook PARK,Seokjoong KIM,Dong Woo SONG
申请号：
US15953141
公开号：
US20180237771A1
申请日:
2018.04.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to an artificially manipulated neovascularization-associated factor for regulating neovascularization and a use thereof. More particularly, the present invention relates to a system for artificially regulating neovascularization, which includes an artificially manipulated neovascularization-associated factor for regulating neovascularization and/or a composition for artificially manipulating the neovascularization-associated factor. In a specific aspect, a neovascularization regulatory system including a neovascularization-associated factor such as artificially manipulated VEGFA, HIF1A, ANGPT2, EPAS1, or ANGPTL4 and/or an expression product thereof is provided.
